New Covid variant spreads from Canada to US, Europe & Asia: What we know about PJ.2.1
A new Covid-19 variant, PJ.2.1, has been identified after emerging in Canada and spreading to the US, Europe, and Asia. While the variant shows increased infectivity, early studies suggest it does not significantly evade vaccine-induced antibodies.
Why it matters
Monitoring new variants is critical for public health preparedness and understanding the ongoing evolution of the virus.
A newly identified Covid-19 variant, PJ.2.1, is spreading across multiple countries after emerging in Canada in May 2026. Researchers have found that the variant may have an increased ability to infect human cells, including those with low levels of the ACE2 receptor. However, early laboratory findings suggest it does not significantly evade antibodies produced by existing Covid-19 vaccines. The findings highlight the need for continued monitoring as the virus evolves.According to a report published in the Journal of Infection, the variant was first detected in Ontario, Canada, on May 2, 2026.It has since spread to several parts of the United States, Europe and Asia. Researchers said wastewater surveillance data showed that PJ.2.1 was the fastest-growing Covid-19 variant in the US at the time of their analysis.In the US, the variant was first identified in a patient in New York City on June 30.
Also covering this story
One other newsroom covered this event. We read that version too.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in